212 related articles for article (PubMed ID: 34350709)
41. Anticancer activity of a Gold(I) phosphine thioredoxin reductase inhibitor in multiple myeloma.
Sze JH; Raninga PV; Nakamura K; Casey M; Khanna KK; Berners-Price SJ; Di Trapani G; Tonissen KF
Redox Biol; 2020 Jan; 28():101310. PubMed ID: 31514052
[TBL] [Abstract][Full Text] [Related]
42. Unveiling the Potential of Innovative Gold(I) and Silver(I) Selenourea Complexes as Anticancer Agents Targeting TrxR and Cellular Redox Homeostasis.
De Franco M; Saab M; Porchia M; Marzano C; Nolan SP; Nahra F; Van Hecke K; Gandin V
Chemistry; 2022 Dec; 28(70):e202201898. PubMed ID: 36106679
[TBL] [Abstract][Full Text] [Related]
43. Auranofin and related heterometallic gold(I)-thiolates as potent inhibitors of methicillin-resistant Staphylococcus aureus bacterial strains.
Hokai Y; Jurkowicz B; Fernández-Gallardo J; Zakirkhodjaev N; Sanaú M; Muth TR; Contel M
J Inorg Biochem; 2014 Sep; 138():81-88. PubMed ID: 24935090
[TBL] [Abstract][Full Text] [Related]
44. Auranofin Resistance in
Ma CI; Tirtorahardjo JA; Jan S; Schweizer SS; Rosario SAC; Du Y; Zhang JJ; Morrissette NS; Andrade RM
Front Cell Infect Microbiol; 2021; 11():618994. PubMed ID: 33816332
[TBL] [Abstract][Full Text] [Related]
45. The antioxidant 2,6-di-tert-butylphenol moiety attenuates the pro-oxidant properties of the auranofin analogue.
Shpakovsky DB; Shtil AA; Kharitonashvili EV; Tyurin VY; Antonenko TA; Nazarov AA; Osipova VP; Berberova NT; Foteeva LS; Schmidt C; Ott I; Milaeva ER
Metallomics; 2018 Mar; 10(3):406-413. PubMed ID: 29399682
[TBL] [Abstract][Full Text] [Related]
46. Investigation of auranofin and gold-containing analogues antibacterial activity against multidrug-resistant Neisseria gonorrhoeae.
Elkashif A; Seleem MN
Sci Rep; 2020 Mar; 10(1):5602. PubMed ID: 32221472
[TBL] [Abstract][Full Text] [Related]
47. Structural basis for the inhibitory mechanism of auranofin and gold(I) analogues against
Zhang Y; Chew BLA; Wang J; Yuan M; Yam JKH; Luo D; Yang L
Comput Struct Biotechnol J; 2023; 21():2137-2146. PubMed ID: 37007650
[No Abstract] [Full Text] [Related]
48. Mononuclear gold(III) complexes with phenanthroline ligands as efficient inhibitors of angiogenesis: A comparative study with auranofin and sunitinib.
Pavic A; Glišić BĐ; Vojnovic S; Warżajtis B; Savić ND; Antić M; Radenković S; Janjić GV; Nikodinovic-Runic J; Rychlewska U; Djuran MI
J Inorg Biochem; 2017 Sep; 174():156-168. PubMed ID: 28675847
[TBL] [Abstract][Full Text] [Related]
49. Selective metabolism of hypothiocyanous acid by mammalian thioredoxin reductase promotes lung innate immunity and antioxidant defense.
Chandler JD; Nichols DP; Nick JA; Hondal RJ; Day BJ
J Biol Chem; 2013 Jun; 288(25):18421-8. PubMed ID: 23629660
[TBL] [Abstract][Full Text] [Related]
50. Repurposing of auranofin: Thioredoxin reductase remains a primary target of the drug.
Zhang X; Selvaraju K; Saei AA; D'Arcy P; Zubarev RA; Arnér ES; Linder S
Biochimie; 2019 Jul; 162():46-54. PubMed ID: 30946948
[TBL] [Abstract][Full Text] [Related]
51. Selective inhibition of endogenous antioxidants with Auranofin causes mitochondrial oxidative stress which can be countered by selenium supplementation.
Radenkovic F; Holland O; Vanderlelie JJ; Perkins AV
Biochem Pharmacol; 2017 Dec; 146():42-52. PubMed ID: 28947276
[TBL] [Abstract][Full Text] [Related]
52. The cellular and molecular pharmacology of auranofin and related gold complexes.
Crooke ST; Snyder RM
Scand J Rheumatol Suppl; 1986; 63():1-18. PubMed ID: 3474775
[TBL] [Abstract][Full Text] [Related]
53. A gold-containing drug against parasitic polyamine metabolism: the X-ray structure of trypanothione reductase from Leishmania infantum in complex with auranofin reveals a dual mechanism of enzyme inhibition.
Ilari A; Baiocco P; Messori L; Fiorillo A; Boffi A; Gramiccia M; Di Muccio T; Colotti G
Amino Acids; 2012 Feb; 42(2-3):803-11. PubMed ID: 21833767
[TBL] [Abstract][Full Text] [Related]
54. Heteroleptic Gold(I)-bisNHC complex with excellent activity in vitro, ex vivo and in vivo against endometrial cancer.
Xiao Q; Liu Y; Jiang G; Liu Y; Huang Y; Liu W; Zhang Z
Eur J Med Chem; 2022 Jun; 236():114302. PubMed ID: 35395440
[TBL] [Abstract][Full Text] [Related]
55. Thioredoxin reductase inhibitor auranofin prevents membrane transport of diphtheria toxin into the cytosol and protects human cells from intoxication.
Schnell L; Dmochewitz-Kück L; Feigl P; Montecucco C; Barth H
Toxicon; 2016 Jun; 116():23-8. PubMed ID: 25911959
[TBL] [Abstract][Full Text] [Related]
56. Gold Nanoclusters for Targeting Methicillin-Resistant Staphylococcus aureus In Vivo.
Xie Y; Liu Y; Yang J; Liu Y; Hu F; Zhu K; Jiang X
Angew Chem Int Ed Engl; 2018 Apr; 57(15):3958-3962. PubMed ID: 29423995
[TBL] [Abstract][Full Text] [Related]
57. Thioredoxin Reductase Is a Valid Target for Antimicrobial Therapeutic Development Against Gram-Positive Bacteria.
Felix L; Mylonakis E; Fuchs BB
Front Microbiol; 2021; 12():663481. PubMed ID: 33936021
[TBL] [Abstract][Full Text] [Related]
58. Synergistic Antimicrobial Titanium Carbide (MXene) Conjugated with Gold Nanoclusters.
Zheng K; Li S; Jing L; Chen PY; Xie J
Adv Healthc Mater; 2020 Oct; 9(19):e2001007. PubMed ID: 32881328
[TBL] [Abstract][Full Text] [Related]
59. Gold Complexes for Therapeutic Purposes: an Updated Patent Review (2010-2015).
Nardon C; Pettenuzzo N; Fregona D
Curr Med Chem; 2016; 23(29):3374-3403. PubMed ID: 27142288
[TBL] [Abstract][Full Text] [Related]
60. Effect of metal complexes on thioredoxin reductase and the regulation of mitochondrial permeability conditions.
Bragadin M; Scutari G; Folda A; Bindoli A; Rigobello MP
Ann N Y Acad Sci; 2004 Dec; 1030():348-54. PubMed ID: 15659816
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
